- Home
- TROO vs NLSP Comparison
TROO vs NLSP Comparison
Compare TROO & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TROO
- NLSP
- Stock Information
- Founded
- TROO 2005
- NLSP 2015
- Country
- TROO Hong Kong
- NLSP Switzerland
- Employees
- TROO N/A
- NLSP N/A
- Industry
- TROO Radio And Television Broadcasting And Communications Equipment
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- TROO Technology
- NLSP Health Care
- Exchange
- TROO Nasdaq
- NLSP Nasdaq
- Market Cap
- TROO 215.4M
- NLSP 243.8M
- IPO Year
- TROO N/A
- NLSP 2021
- Fundamental
- Price
- TROO $1.73
- NLSP $3.37
- Analyst Decision
- TROO
- NLSP
- Analyst Count
- TROO 0
- NLSP 0
- Target Price
- TROO N/A
- NLSP N/A
- AVG Volume (30 Days)
- TROO 10.2K
- NLSP 626.4K
- Earning Date
- TROO 12-03-2024
- NLSP 11-29-2024
- Dividend Yield
- TROO N/A
- NLSP N/A
- EPS Growth
- TROO N/A
- NLSP N/A
- EPS
- TROO N/A
- NLSP N/A
- Revenue
- TROO $3,569,000.00
- NLSP N/A
- Revenue This Year
- TROO N/A
- NLSP N/A
- Revenue Next Year
- TROO N/A
- NLSP N/A
- P/E Ratio
- TROO N/A
- NLSP N/A
- Revenue Growth
- TROO N/A
- NLSP N/A
- 52 Week Low
- TROO $0.73
- NLSP $3.00
- 52 Week High
- TROO $4.89
- NLSP $29.08
- Technical
- Relative Strength Index (RSI)
- TROO 30.64
- NLSP 37.40
- Support Level
- TROO $1.70
- NLSP $3.01
- Resistance Level
- TROO $1.90
- NLSP $3.55
- Average True Range (ATR)
- TROO 0.20
- NLSP 0.43
- MACD
- TROO -0.00
- NLSP -0.01
- Stochastic Oscillator
- TROO 7.62
- NLSP 20.98
About TROO TROOPS Inc.
TROOPS Inc is a conglomerate group of various businesses with its headquarters based in Hong Kong. The group is principally engaged in money lending business in Hong Kong providing mortgage loans to high quality target borrowers, property investment to generate additional rental income and the development, operation and management of an online financial marketplace that provides one-stop financial technology solutions including API services by leveraging artificial intelligence, large data and blockchain, and cloud computing (SaaS). It derives revenue from Hong Kong and Australia. Majority of its revenue generates from domestic market.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.